Can Health, Lifestyle Changes Protect Elders from Alzheimer’s?
Personalized health and lifestyle changes such as increased exercise and socializtion can delay or even prevent memory loss for higher-risk older adults.

University of California San Francisco
Give to UCSFPersonalized health and lifestyle changes such as increased exercise and socializtion can delay or even prevent memory loss for higher-risk older adults.
A previously unknown signaling cycle stemming from our sense of taste helps suppress our appetites.
Breast cancer was the second most commonly diagnosed cancer in women, after skin cancer – accounting for 31% of all new female cancer diagnoses in 2022. Yet, determining who is most at risk of breast
University of California prostate cancer experts will share clinical insights at the first annual PSMA Conference, “PSMA PET and RLT: Present and Future.” The conference will take place online and in
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities.
A gene expression test can accurately predict the best treatment for meningioma patients by measuring the aggressiveness of their tumors and adjusting treatment accordingly.
It’s been known for many years that people who smoke tobacco have poor blood vessel function. Now, a team of researchers at UC San Francisco has shown that people who smoke marijuana have the same
New research shows that in the U.S., the longevity gap between women and men has been widening for more than a decade, with women outliving men by an average of six years.
Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later.
A bad night of sleep was associated with a 15% greater risk of having an atrial fibrillation (A-Fib) episode the following day, along with conditions like blood clots, heart failure, stroke and other heart-related problems.
A phase 1 trial shows promise in treating metastatic prostate cancer with a single priming dose of radioligand therapy and immunotherapy.
UCSF's Adam Boxer, MD, PhD, and Harvard neurologist Reisa Sperling, MD, review the history of clinical trials over the past 30 years in Alzheimer’s research with what was learned and how new biomarkers and clinical trial approaches are being used to find more effective treatments in a more efficient way than in the past.
UCSF researchers developed a new neighborhood-based model of care that brings medicine to people immediately after being diagnosed with hepatitis C.
A UCSF-led found that people who are experiencing homelessness have a 16-fold higher rate of sudden death from heart attacks, as well as other causes.
Being suspended from school or sent to the office is tied to a big drop in grade point average (GPA), especially for Black and Latinx children.
UCSF experts to discuss amyloid therapies and dementia research at CTAD conference, addressing equity, novel treatments, and innovative studies.
Scientists found that the nervous system tamps down allergic response, which could change how asthma, Crohn’s and other inflammatory diseases are treated.
A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two other drugs to see if their effects can be amplified.
UCSF's HS PROGRESS study aims to understand and treat Hidradenitis Suppurativa, an often debilitating condition disproportionately affecting women and people of color.
Patients of acute kidney injury might not need as much dialysis as patients with end-stage kidney disease, and might benefit more from weaning off dialysis to avoid risk for heart disease, infection, organ damage and death.
A small device placed behind the ear targets the nervous system to help reduce pain and provide relief for kids with irritable bowel syndrome (IBS).
FDA approves palovarotene (Sohonos) for rare FOP, reducing HO by 54%. Significant step in improving lives of affected patients.
Vizient Inc. has named UCSF Health as a Top Performer for its high-quality patient care in the 2023 Bernard A. Birnbaum, MD, Quality Leadership Ranking.
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
UCSF Health achieves 150 robotic focal HIFU procedures for prostate cancer, pioneering precision therapy with minimal side effects, prioritizing quality of life preservation.
Using both cannabis and tobacco increases depression and anxiety risk, highlighting the need for integrated support, says UC San Francisco study.
A UCSF telecare program improves outcomes for patients with dementia and lightens the load for unpaid caregivers while cutting Medicare costs.
Researchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
Babies who experience malnutrition may also experience worse cognitive development and have higher chances of death.
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.